Cops bust narco syndicate, seize Rs 1 crore worth drugs

NEW DELHI: With the arrest of three men, including the kingpin, the Crime Branch of Delhi Police on Friday claimed to have busted a ‘nationwide narco syndicate’ involved in the manufacturing and distribution of banned narcotic drugs and psychotropic substances, including Alprazolam tablets and Triprolidine Hydrochloride and Codeine Phosphate syrup across the country.

Police have also seized tablet and syrup worth approximately `1 crore recovered and machine used in preparation of triprolidine hydrochloride and Codeine Phosphate syrup including packaging materials.

The accused were identified as Samaludden a.k.a Sadik (28), a resident of Agra, Mohd. Gulzar (34), a resident of Narela and Salman (28), a resident of Baghpat in Uttar Pradesh.

Police said that a complete setup including machinery in manufacturing the recovered drug has also been seized in the city’s Bawana area and the seized contraband has been traced to suppliers in Uttar Pradesh, with connections to various distribution channels extending into Haryana, Delhi, Uttarakhand, indicating a complex inter-state operation.

The entire syndicate was unearthed after a tip-off was received on December 25 which led to the arrest of three accused who were in possession of 1.80,000 tablets of Alprazolam tablets and 9,000 bottles of triprolidine Hydrochloride and Codeine Phosphate Syrup under the name of Kojex and O- Curex-T, classified as a commercial quantity under the NDPS Act. Special Commissioner of Police (Crime) Devesh Chandra Srivastva said that Sadik, the kingpin of the syndicate, who also possesses the degree of B-Pharma from Pratap University Jaipur, and Salman planned to set up a factory to manufacture the Codeine based Syrup and habit-forming drugs like Alphrazolam, Tramadol etc.

“Sadik has also a facebook ID in the name of Sandeep Saini, in that profile DP, he put the picture of medicine, so that he can get customers through social media, without being identified. He had set up the factory in Bawana with the help of Salman and Gulzar, in a rented property in Bawana Industrial Area,” said Special CP, while divulging the details of interrogation of the accused.

The Special CP further said that Gulzar, a graphics designer, also registered a firm under the name Abheshifa, pharmaceutical marketing company and he is the main associate of Salman and Sadik.

“He worked as the supervisor cum in-charge of illegal factory setup. He also designed the label of recovered medicines and also helped Sadik and Salman to get the labels printed illegally,” said the Special CP.

The officer said they were using a forge manufacturing license number, batch number. Even the address and QR code mentioned on the recovered Syrup are also forged. “They were planning to set up fake medicine(tablet) manufacturing plant,” the officer added.

Related Posts

  • Pharma
  • June 18, 2025
  • 98 views
Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharmaceuticals said that the United States’ Food and Drug Administration (FDA) has concluded inspection of its manufacturing facility in Monroe, North Carolina. Glenmark Pharmaceuticals said that the United States’…

  • Pharma
  • June 18, 2025
  • 87 views
ED conducts searches across six States in drug trafficking case

The Enforcement Directorate on Tuesday conducted searches at 15 locations, including the premises of five pharmaceutical companies, across six States in connection with a drug trafficking case registered in Punjab.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

ED conducts searches across six States in drug trafficking case

ED conducts searches across six States in drug trafficking case

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base